F Goknur Akarca, MD

Title(s)RESIDENT PHYSICIAN, Pathology
SchoolSchool of Medicine
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-2254-3279 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Ankara University Medical School, Ankara, TURKEYMD07/2013Medicine
    Gazi University Medical School, Ankara, TURKEYResidency07/2018Anatomical Pathology
    Dana Farber Cancer Institute, Boston, MA, USAResearch scholarship08/2019Medical Oncology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Non-conventional dysplasia is frequently associated with low-grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease. Histopathology. 2023 Aug; 83(2):276-285. Akarca FG, Yozu M, Alpert L, Kovári BP, Zhao L, Salomao M, Liao X, Westerhoff M, Lauwers GY, Choi WT. PMID: 37055929.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    2. Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia. Gastroenterology. 2022 02; 162(2):468-481. Redston M, Noffsinger A, Kim A, Akarca FG, Rara M, Stapleton D, Nowden L, Lash R, Bass AJ, Stachler MD. PMID: 34757142; PMCID: PMC9341495.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    3. Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival. J Immunother Cancer. 2021 09; 9(9). de Klerk LK, Patel AK, Derks S, Pectasides E, Augustin J, Uduman M, Raman N, Akarca FG, McCleary NJ, Cleary JM, Rubinson DA, Clark JW, Fitzpatrick B, Brais LK, Cavanaugh ME, Rode AJ, Jean MG, Lizotte PH, Nazzaro MJ, Severgnini M, Zheng H, Fuchs CS, Enzinger PC, Bass AJ. PMID: 34593617; PMCID: PMC8487210.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    4. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. Nat Genet. 2021 06; 53(6):881-894. Wu Z, Zhou J, Zhang X, Zhang Z, Xie Y, Liu JB, Ho ZV, Panda A, Qiu X, Cejas P, Cañadas I, Akarca FG, McFarland JM, Nagaraja AK, Goss LB, Kesten N, Si L, Lim K, Liu Y, Zhang Y, Baek JY, Liu Y, Patil DT, Katz JP, Hai J, Bao C, Stachler M, Qi J, Ishizuka JJ, Nakagawa H, Rustgi AK, Wong KK, Meyerson M, Barbie DA, Brown M, Long H, Bass AJ. PMID: 33972779; PMCID: PMC9124436.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    5. Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas. Ann Oncol. 2020 08; 31(8):1011-1020. Derks S, de Klerk LK, Xu X, Fleitas T, Liu KX, Liu Y, Dietlein F, Margolis C, Chiaravalli AM, Da Silva AC, Ogino S, Akarca FG, Freeman GJ, Rodig SJ, Hornick JL, van Allen E, Li B, Liu SX, Thorsson V, Bass AJ. PMID: 32387455; PMCID: PMC7690253.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    6. The Contribution of Additional Sampling in Cholecystectomy Materials: A Multicenter Prospective Study. Turk Patoloji Derg. 2020; 36(3):188-194. Abdullazade S, Akarca FG, Esendagli G, Turhan N, Erden E, Savas B, Markoc F, Tuncel D, Yilmaz BÖ, Saka B, Keser SH, Erhan SS, Gucin Z, Sagol Ö, Agalar AA, CelIk S, Ozer H, Seven IE, CelIkel ÇA, Ekinci Ö, Egilmez HR, Balci S, Akyol G. PMID: 32364613; PMCID: PMC10510599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer. Cancer Discov. 2020 02; 10(2):288-305. Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, Papageorge AG, Stachler MD, Liao J, Zhou J, Wu Z, Akarca FG, de Klerk LK, Derks S, Pierobon M, Hoadley KA, Wang TC, Church G, Wong KK, Petricoin EF, Cox AD, Lowy DR, Der CJ, Bass AJ. PMID: 31771969; PMCID: PMC7007383.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    8. A Retrospective Evaluation of the Epithelial Changes/Lesions and Neoplasms of the Gallbladder in Turkey and a Review of the Existing Sampling Methods: A Multicentre Study. Turk Patoloji Derg. 2018; 34(1):41-48. Esendagli G, Akarca FG, Balci S, Argon A, Erhan SS, Turhan N, Zengin NI, Keser SH, Çelik B, Bulut T, Abdullazade S, Erden E, Savas B, Bostan T, Sagol Ö, Agalar AA, Kepil N, Karslioglu Y, Günal A, Markoç F, Saka B, Özgün G, Özdamar SO, Bahadir B, Kaymaz E, Isik E, Ayhan S, Tunçel D, Yilmaz BÖ, Çelik S, Karabacak T, Seven IE, Çelikel ÇA, Gücin Z, Ekinci Ö, Akyol G. PMID: 28984336.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    F Goknur's Networks
    Concepts (68)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _